- Corporate Officers - D
- Dunn John Michael
Insider Trading History of Dunn John Michael
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Dunn John Michael since 2006.
The trader's CIK number is 1238648.
At the time of the last reporting, Dunn John Michael was the EVP, New Ventures of Acer Therapeutics Inc.. (stock ticker symbol ACER).
Also see all insider trading activities at Acer Therapeutics Inc..
Note that in the past
DUNN JOHN MICHAEL also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biogen Inc. (BIIB) by Dunn John Michael
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | BIIB | 0 | $0 | 5,466 | $278,028 | 3,633 | $0 |
| 2008 | BIIB | 0 | $0 | 18,449 | $1,245,744 | 16,603 | $28,491,847 |
| 2007 | BIIB | 0 | $0 | 63,965 | $3,345,370 | 53,986 | $1,943,550 |
| 2006 | BIIB | 0 | $0 | 20,954 | $997,812 | 20,954 | $741,142 |
Yearly summary of insider trading at Acer Therapeutics Inc. (ACER) by Dunn John Michael
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ACER | 21,428 | $74,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Immunic, Inc. (VTL) by Dunn John Michael
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | VTL | 2,500 | $7,707 | 0 | $0 | 0 | $0 |
| 2015 | VTL | 9,385 | $63,929 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Dunn John Michael:
1. Biogen Inc. (BIIB)
2. Acer Therapeutics Inc. (ACER)
3. Immunic, Inc. (VTL)
Table 1. Insider trading of Biogen Inc. (BIIB) by Dunn John Michael
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-02-19 | BIIB | Sale | 3,208 | 50.90 | 163,300 |
| 2009-02-11 | BIIB | Sale | 2,258 | 50.81 | 114,728 |
| 2009-02-06 | BIIB | Option Ex | 3,633 | .00 | 0 |
| 2008-07-22 | BIIB | Sale | 6,485 | 71.50 | 463,677 |
| 2008-07-22 | BIIB | Option Ex | 6,485 | 43.50 | 282,097 |
| 2008-07-21 | BIIB | Sale | 6,485 | 67.50 | 437,737 |
| 2008-07-21 | BIIB | Option Ex | 6,485 | 4,350.00 | 28,209,750 |
| 2008-04-14 | BIIB | Sale | 3,212 | 64.19 | 206,184 |
| 2008-02-12 | BIIB | Sale | 2,267 | 60.94 | 138,146 |
| 2008-02-06 | BIIB | Option Ex | 3,633 | .00 | 0 |
| 2007-07-25 | BIIB | Option Ex | 20,000 | 43.50 | 870,000 |
| 2007-07-25 | BIIB | Sale | 20,000 | 57.75 | 1,155,000 |
| 2007-06-27 | BIIB | Option Ex | 15,352 | 35.37 | 543,000 |
| 2007-06-27 | BIIB | Sale | 15,352 | 52.90 | 812,120 |
| 2007-04-23 | BIIB | Option Ex | 15,000 | 35.37 | 530,550 |
| 2007-04-23 | BIIB | Sale | 18,760 | 48.90 | 917,364 |
| 2007-04-20 | BIIB | Sale | 7,519 | 46.02 | 346,016 |
| 2007-02-13 | BIIB | Sale | 2,334 | 49.22 | 114,870 |
| 2007-02-06 | BIIB | Option Ex | 3,634 | .00 | 0 |
| 2006-11-15 | BIIB | Option Ex | 7,850 | 35.37 | 277,654 |
| 2006-11-15 | BIIB | Sale | 7,850 | 49.00 | 384,650 |
| 2006-10-31 | BIIB | Option Ex | 13,104 | 35.37 | 463,488 |
| 2006-10-31 | BIIB | Sale | 13,104 | 46.79 | 613,162 |
Table 2. Insider trading of Acer Therapeutics Inc. (ACER) by Dunn John Michael
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-07-24 | ACER | Buy | 21,428 | 3.50 | 74,998 |
Table 3. Insider trading of Immunic, Inc. (VTL) by Dunn John Michael
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-06-14 | VTL | Buy | 2,500 | 3.08 | 7,707 |
| 2015-10-23 | VTL | Buy | 7,385 | 6.76 | 49,929 |
| 2015-10-26 | VTL | Buy | 2,000 | 7.00 | 14,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Dunn John Michael
(EVP, New Ventures of Acer Therapeutics Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.